sj-pdf-1-tan-10.1177_1756286420987941 – Supplemental material for Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination

• Main Authors: Kappos, Ludwig, Cohan, Stanley, Arnold, Douglas L., Robinson, Randy R., Holman, Joan, Fam, Sami, Parks, Becky, Xiao, Shan, Castro-Borrero, Wanda
• Format: Text
• Language: unknown
• Published: SAGE Journals 2021
• Subjects: 110904 Neurology and Neuromuscular Diseases; FOS Clinical medicine; 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified; sami
• Online Access: https://dx.doi.org/10.25384/sage.14131909.v1; https://sage.figshare.com/articles/journal_contribution/sj-pdf-1-tan-10_1177_1756286420987941_Supplemental_material_for_Safety_and_efficacy_of_daclizumab_beta_in_patients_with_relapsing_multiple_sclerosis_in_a_5-year_open-label_study_EXTEND_final_results_following_early_termination/14131909/1

Supplemental material, sj-pdf-1-tan-10.1177_1756286420987941 for Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination by Ludwig Kappos, Stanley Cohan, Douglas L. Arnold, Randy R. Robinson, Joan Holman, Sami Fam, Becky Parks, Shan Xiao and Wanda Castro-Borrero in Therapeutic Advances in Neurological Disorders